» Articles » PMID: 9008596

Disease Patterns and Tissue Cytokine Profiles in Giant Cell Arteritis

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 1997 Jan 1
PMID 9008596
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine whether clinical heterogeneity in patients with giant cell arteritis (GCA) is correlated with different patterns in the tissue-specific inflammatory response.

Methods: Twenty-three patients with typical histomorphologic findings of GCA were grouped according to the presence or absence of jaw claudication and/or visual abnormalities, fever, concomitant polymyalgia rheumatica (PMR), and histologic evidence of giant cell formation. The inflammatory response in temporal artery biopsy specimens was characterized by semiquantification of cytokine messenger RNA (mRNA) transcripts using reverse transcriptase-polymerase chain reaction, followed by oligonucleotide hybridization with cytokine-specific probes. Clinical patterns were then correlated with profiles of tissue cytokines.

Results: Inflammatory cytokines were expressed in all temporal artery tissues. In situ synthesis of interleukin-2 (IL-2), interferon-gamma (IFN gamma), and IL-1 beta mRNA, but not of IL-10 and IL-12 mRNA, distinguished different patterns of inflammation, and these patterns correlated with clinical manifestations of the disease. Patients with evidence of ischemic symptoms, indicated by jaw claudication and/or visual symptoms, typically expressed higher concentrations of IFN gamma mRNA (P = 0.008) and IL-1 beta mRNA (P = 0.02). Presence of fever was correlated with lower copy numbers of IFN gamma (P = 0.02). Formation of giant cells in the granulomatous infiltrates was associated with the local synthesis of IFN gamma mRNA (P = 0.003). Tissue from GCA patients with concomitant PMR contained higher levels of IL-2 mRNA transcripts (P = 0.001).

Conclusion: Variations in the clinical presentation of GCA were correlated with cytokine mRNA expression in the affected temporal arteries. Differences in the effector functions of tissue-infiltrating T cells distinguished disease patterns in which either local ischemic symptoms or systemic involvement was dominant, or in which there was co-occurrence of PMR. Definition of different patterns of inflammation in GCA might, therefore, facilitate the design of differentiated therapeutic approaches.

Citing Articles

Giant Cell Arteritis: Advances in Understanding Pathogenesis and Implications for Clinical Practice.

Paroli M, Caccavale R, Accapezzato D Cells. 2024; 13(3.

PMID: 38334659 PMC: 10855045. DOI: 10.3390/cells13030267.


Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica.

van der Geest K, Sandovici M, Nienhuis P, Slart R, Heeringa P, Brouwer E Front Med (Lausanne). 2022; 9:902155.

PMID: 35733858 PMC: 9207253. DOI: 10.3389/fmed.2022.902155.


Ultrasound Technologies and the Diagnosis of Giant Cell Arteritis.

Jianu D, Jianu S, Dan T, Munteanu G, Birdac C, Motoc A Biomedicines. 2021; 9(12).

PMID: 34944617 PMC: 8698303. DOI: 10.3390/biomedicines9121801.


Targeted RNA Sequencing of Formalin-Fixed, Paraffin-Embedded Temporal Arteries From Giant Cell Arteritis Cases Reveals Viral Signatures.

Bubak A, Mescher T, Mariani M, Frietze S, Hassell Jr J, Niemeyer C Neurol Neuroimmunol Neuroinflamm. 2021; 8(6).

PMID: 34493606 PMC: 8424492. DOI: 10.1212/NXI.0000000000001078.


Dysregulated Expression of Arterial MicroRNAs and Their Target Gene Networks in Temporal Arteries of Treatment-Naïve Patients with Giant Cell Arteritis.

Kuret T, Lakota K, cucnik S, Jurcic V, Distler O, Rotar Z Int J Mol Sci. 2021; 22(12).

PMID: 34204585 PMC: 8234166. DOI: 10.3390/ijms22126520.